Effect of morphine on activity of five selected lysosomal enzymes and kidneys of mice

• Autorzy: Witek B. , Ochwanowska E. , Wrobel A. , Kolataj A.
• Języki publikacji: EN

Abstrakty

EN

The experiment was carried out on 90 Swiss male mice divided into 9 groups (n=10). Over 4, 10 and 14 days mice of three control groups (I-III) were injected with 250 μl 0.9% NaCl solution daily, and those from six experimental groups (A-F) with 250 μl 0.9% NaCl solution containing 20 or 30 mg morphine hydrochloride per kg body weight. The injections were given intramuscularly once a day between 9:00-10:00 a.m. for 4, 10 and 14 days. In the lysosomal fraction of the liver and kidney the activities of acid phosphatase, lysosomal esterase, β-glucuronidase, β-galactosidase, and β-N-acetyl-hexosaminidase were estimated. Morphine increased the activity of all examined enzymes except EL, which activity was statistically proven to decrease in liver and kidneys after 10 days morphine administration in both doses.

Słowa kluczowe

EN

morphine; enzyme activity; lysosomal enzyme; kidney; mice; mouse; liver

• Wydawca: -
• Czasopismo: Animal Science Papers and Reports
• Rocznik: 2011
• Tom: 29
• Numer: 2
• Opis fizyczny: p.151-159,ref.

Twórcy

autor

Witek B.

• Department of Animal Physiology, Institute of Biology, The Jan Kochanowski University in Kielce, 25-406 Kielce, Poland

autor

Ochwanowska E.

autor

Wrobel A.

autor

Kolataj A.

Bibliografia

• BAGSHAW R.D., MAHURAN D.J., CALLAHAN J.W., 2005 – Lysosomal membrane proteomics and biogenesis of lysosomes. Molecular Neurobiology 32, 27-42.
• BARRETT A.J., 1972 – Lysosomal enzymes. In: Lysosomes, a Laboratory Handbook”. Ed. J.T.Dingle, North-Holland Publishing Company, Amsterdam, New York, Oxford, 46-135.
• BARRETT A.J., HEATH MF., 1977 – Lysosomal enzymes. In: Lysosomes. a Laboratory Handbook.Ed. J.T. Dingle, North-Holland Publishing Company, Amsterdam, New York, Oxford, 19-145.
• BEAUFAY H., 1972 – Methods for isolation of lysosomes. In: Lysosomes, a Laboratory Handbook.Ed. J.T. Dingle, North-Holland Publishing Company Amsterdam 1972 1-45.
• BHAT R.S., BHASKARAN M., MONGIA A., HITOSUGI N., SINGHAL P.C., 2004 – Morphineinduced macrophage apoptosis: oxidative stress and strategies for modulation. Journal of Leukocyte Biology 75, 1131-1138.
• BOUNDY V.A., GOLD S.J., MESSER C.J., CHEN J., SON J.H., JOH T.H., NESTLER E.J., 1998 –Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice. The Journal of Neuroscience 18, 9989-9995.
• CUERVO A.M., DICE J.F., 2000 – When lysosomes get old. Experimental Gerontology 35, 119-131.
• DUEE P.H., PEGORIER J.P., MANOUBI L., HERBIN C., KOHL C., GIRARD J., 1985 – Hepatic triglyceride hydrolysis and development of ketogenesis in rabbits. American Journal of Physiology 249, E478-E484.
• DURAN-REYES G., GONZALES-MACIAS G., HICKS I.J., 1995 – Lysosomal system in hormonal mechanisms. Ginecologia Obstetricia de Mexico 63, 68-73.
• DE GRAAF M., BOVEN E., SCHEEREN H.W., HAISMA H.J., PINEDO H.M., 2002 – Betaglucuronidase-mediated drug release. Current Pharmaceutical Development 8, 1391-1403.
• HALL J.C., JACOBETZ D.R., LA MARCHE M.D., KOCHINS J., TUBBS C.E., 1997 –Purification, characterization and expression of rat epididymal β-D-galactosidase. Biochemistry and Molecular Biology International 42, 443-451.
• IWATA T., UCHIDA S., HORI M., SAKAI K., TOWATARI T., KIDO H., 1999 – Human parathyroid hormone increases urinary excretion of lysosomal enzymes in rats. Life Science 65, 1725-1732.
• IZAGIRRE U., ANGULO E., WADE S.C., GWYNN I., MARIQOMEZ I., 2009 – Betaglucuronidase and hexosaminidase are marker enzymes for different compartments of the endolysosomal system in mussel digestive cells. Cell and Tissue Research 335, 441-454.
• KHARASCH E.D., FRINK E.J., ZAGER R., BOWDLE T.A., ARTRU A., NOGAMI W.M., 1997 –Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 86, 1238-1253.
• KIRSCHKE H., WIEDERANDERS B., 1984 – Methoden zur Aktivitätsbestimmung von Proteinasen. Martin-Luther-Universität Halle-Wittenberg Wissenschaftliche Beitrage Halle/Salle 11-17.
• KOŁĄTAJ A., ŚLIWA-JÓŹWIK A., JÓŹWIK A., 2001 – The lysosomal cell complex as a stress response indicator. Animal Science Papers and Reports 3, 177-192.
• KROEMER H.K., KLOTZ U., 1992 – Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clinical Pharmacokinetics 23, 292-310.
• KRUMHOLZ W., WEIDENBUSCH H., MENGES T., KELLER G., HEMPELMANN G., 2001 –The influence of intravenous anesthetics on the activity of enzymes released from polymorphonuclear leucocytes in vitro. European Journal of Anesthesiology 18, 151-158.
• KUMAŃSKI K., 2009 – Influence of vitamin A and restricted protein in food on lysosomal enzyme activity in the mouse liver and kidney. Edited and published by the Warsaw Agricultural University (Wydawnictwo Naukowe SGGW), Warszawa, 1-76.
• LI Y., QIN Y., LI H., WU R., YAN C., DU H., 2007 – Lysosomal acid lipase over-expression disrupts lamellar body genesis and alveolar structure in the lung. International Journal of Experimental Pathology 88, 427-436.
• LIGA A.B., UKHINA T.V., SHIMANOVSKI N.L., 2008 – Activity lysosomal enzymes in rat skin fibroblasts after treatment with progesterone and new gestagen ABMP. Bulletin of Experimental Biology and Medicine 145, 44-46.
• LÖTSCH J., 2005 – Pharmacokinetic-pharmacodynamic modeling of opioids. Journal of Pain and Symptom Management 5, S90-S103.
• MYŚLIWIEC M., ZORENA K., BALCERSKA A., MYŚLIWSKA J., LIPOWSKI P., RACZYNSKA K., 2006 – The activity of N-acetyl-beta-D-glucosaminidase and tumor necrosis factor-alpha at early stage of diabetic retinopathy development in type 1 diabetes mellitus children. Clinical Biochemistry 39, 851-856.
• PRICE R.G., 1992 – Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine:methods and clinical applications. European Journal of Clinical Chemistry and Clinical Biochemistry:Journal of the Forum of European Clinical Chemistry Societies 30, 693-705.
• ROBERTS E.A., DERETIC V., 2008 – Autophagic proteolysis of long-lived proteins in nonliver cells. Methods in Molecular Biology 445, 111-117.
• SAVAGE S.R., 1999 – Opioid use in the management of chronic pain. Medical Clinics North America 83, 761-786.
• SELYE H., 1936 – A Syndrome Produced by Diverse Noxious Agents. Nature 138, 32-34.
• SHARP B.M., 2006 – Multiple opioid receptors on immune cells modulate intracellular signaling.Brain Behavior and Immunity 20, 9-14.
• STERNBERG W.F., RIDGWAY C.G., 2003 – Effect of gestational stress and neonatal handling on pain, analgesia, and stress behavior of adult mice. Physiology and Behavior 78, 375-383.
• WATTERSON G., HOWARD R., GOLDMAN A., 2004 – Peripheral opioids in inflammatory pain.Archives of Disease in Childhood 89, 679-681.
• WITEK B., 2000 – Fizjologia reakcji stresowej i model lizosomalnego układu degradacyjnego (Physiology of stress reaction and model of lysosomal degradation system) In Polish. Edited and published by Warsaw Agricultural University (Wydawnictwo Naukowe SGGW), 1-60.
• WITEK B., OCHWANOWSKA E., RAFAY J., KOŁĄTAJ A., CHRENEK P., SUVEGOVA K.,JURCIK R., SIROTKIN A., DARLAK K., 2005 – Effect of ghrelin on activities of some lysosomal hydrolases in rabbits. Neuroendocrinology Letters 26, 397-400.
• WITEK B., GRANICZKA A., OCHWANOWSKA E., KOŁĄTAJ A., 2006 – Aktywność enzymów lizosomowych w wątrobie i nerkach myszy po iniekcjach glukagonu. Medycyna Weterynaryjna 62,717-719.
• WOŹNIAK A., DREWA T., ROZWODOWSKA M.. DREWA G., LAMBRECHT W., WIŚNIEWSKA I., 2002 – Activity of some lysosomal enzymes in serum and in tumors of patients with squamous cell lung carcinoma. Neoplasma 49, 10-15.